Armistice Capital’s Bluejay Diagnostics BJDX Stock Holding History
Bought
Maintained
Sold
Other funds holding BJDX
Armistice Capital's BJDX Position: Q3 2026 in Review
Armistice Capital sold out of Bluejay Diagnostics (BJDX) in Q3 2026, closing a stake of 32,750 shares — an estimated $157K sold.
Armistice Capital first reported a position in BJDX in Q4 2023 and held it in 4 quarters. The position peaked at $157K in Q2 2026. 13 funds tracked by Wall St. Rank hold BJDX as of Q3 2026.
- Armistice Capital reported no remaining Bluejay Diagnostics position as of Q3 2026 after selling out during the quarter.
- Armistice Capital sold 32,750 Bluejay Diagnostics shares in Q3 2026, an estimated $157K.
- Armistice Capital first reported a position in Bluejay Diagnostics in Q4 2023 and held it in 4 quarters.
- Armistice Capital's Bluejay Diagnostics position peaked at $157K in Q2 2026.
- 13 funds tracked by Wall St. Rank held Bluejay Diagnostics as of Q3 2026.
Based on Armistice Capital's 13F filing for Q3 2026, filed 16 Nov 2026.